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There is growing evidence for exaggerated oscillatory neuronal synchronisation in patients
with Parkinson’s disease (PD). In particular, oscillations at around 20Hz, in the so-called
beta frequency band, relate to the cardinal symptoms of bradykinesia and rigidity. Deep
brain stimulation (DBS) of the subthalamic nucleus (STN) can significantly improve these
motor impairments. Recent evidence has demonstrated reduction of beta oscillations
concurrent with alleviation of PD motor symptoms, raising the possibility that suppression
of aberrant activity may mediate the effects of DBS. Here we review the evidence
supporting suppression of pathological oscillations during stimulation and discuss how
this might underlie the efficacy of DBS. We also consider how beta activity may provide a
feedback signal suitable for next generation closed-loop and intelligent stimulators.
Keywords: Parkinson’s disease, basal ganglia, deep brain stimulation, oscillations, neurophysiology
INTRODUCTION
Converging evidence from experimental and clinical studies indi-
cates that deep brain stimulation (DBS) of the basal ganglia (BG)
can be a very successful therapeutic approach in Parkinson’s dis-
ease (PD). Accordingly, there has been a progressive shift from
lesion techniques, which had been used for decades, to stimu-
lation techniques, which have the major advantage of being—at
least partly—reversible. Introduced in the early 1990’s, DBS, par-
ticularly of the subthalamic nucleus (STN), is now a common
therapeutic solution for advanced patients. However, the mech-
anisms underlying its remarkable efficacy in reducing parkinso-
nian symptoms remain largely unclear. Here, we will explore the
hypothesis that DBS of the STN suppresses pathological synchro-
nisation at low frequencies (13–35Hz) and that this contributes
to symptomatic benefit. To this end we will begin with a critical
discussion of the evidence that such oscillatory synchronisation
underlies motor impairment in PD and briefly discuss the effi-
cacy of current high-frequency DBS regimes, before considering
the evidence that DBS does suppress oscillatory synchronisation.
EXCESSIVE OSCILLATIONS IN THE BETA BAND ARE A
NEUROPHYSIOLOGICAL SIGNATURE OF PATIENTS
WITH PARKINSON’S DISEASE
There is extensive evidence indicating that abnormally synchro-
nised activity patterns in the beta band (13–35Hz) are a hallmark
of untreated PD. These activities have principally been found in
recordings from the STN and globus pallidus interna (GPi) of
PD patients withdrawn from their medication. Activities synchro-
nised in this band have been captured in single-unit recordings
and cross-correlograms of neuron pairs (Levy et al., 2002a,b;
Amirnovin et al., 2004; Kuhn et al., 2005). They have also
been recorded in the local field potentials (LFPs) from striatum
(Sochurkova and Rektor, 2003), STN (Brown et al., 2001; Priori
et al., 2002, 2004; Williams et al., 2002, 2003, 2005; Kuhn et al.,
2004; Bronte-Stewart et al., 2009), and GPi (Brown et al., 2001;
Priori et al., 2002; Silberstein et al., 2003). Oscillations recorded
from the STN and GPi are ipsilaterally coherent in the beta band
(Brown et al., 2001; Cassidy et al., 2002; Foffani et al., 2005)
and are coherent with electroencephalographic and magnetoen-
cephalographic activities recorded over motor cortex in the same
frequency band (Marsden et al., 2001; Williams et al., 2002; Lalo
et al., 2008; Hirschmann et al., 2011; Litvak et al., 2011). In addi-
tion, it has recently been shown that beta oscillations are coherent
bilaterally between the two STNs suggesting existence of a strong
functional connection between these nuclei, although the exact
anatomy of this connection remains to be established (de Solages
et al., 2010).
The beta frequency band is broad and there may be function-
ally important subdivisions within it (Priori et al., 2004;Marceglia
et al., 2006, 2007; Lopez-Azcarate et al., 2010). In particular,
LFP power in the lower (<20Hz) beta band is more dramat-
ically suppressed by levodopa and apomorphine than that in
the upper (>20Hz) beta band (Priori et al., 2004; Marceglia
et al., 2006). Such distinctions would be consistent with the exis-
tence of several oscillating circuits, each with its own resonance
frequency. There is evidence that activity in the STN is pref-
erentially coupled with mesial cortical areas in the upper beta
frequency band, while correlated with sensorimotor cortex in
the lower beta band (Fogelson et al., 2006). These findings are
mirrored in the distribution of cortical beta activity in healthy
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subjects (Pfurtscheller et al., 2003). Accordingly, different BG-
cortical loops may be effectively tuned to activities in different
frequency bands.
What is the evidence that oscillatory activity in the beta fre-
quency band may contribute to motor impairment in patients
with PD? There are several reports on levodopa-induced suppres-
sions of beta LFP power and the incidence of neurons oscillating
over this frequency range in the STN correlates with treat-
ment induced improvement in bradykinesia and rigidity, but not
tremor (Kuhn et al., 2006, 2009;Weinberger et al., 2006; Ray et al.,
2008). Less clear is whether oscillatory activity in the beta band
off medication state correlates with motor impairment in the off
medication state. Reports vary with respect to whether they found
(Chen et al., 2010; Lopez-Azcarate et al., 2010; Pogosyan et al.,
2010; Ozkurt et al., 2011) or did not find such a correlation (Kuhn
et al., 2006, 2009; Weinberger et al., 2006; Ray et al., 2008). This
variability may relate to the absence of normalisation in some
studies to offset the effects of microsubthalamotomy and target-
ing variance between sides and patients (Chen et al., 2010). Some
investigations have also reported a correlation between level of
activity in the beta band off medication and levodopa-induced
improvement in bradykinesia and rigidity (Weinberger et al.,
2006; Zaidel et al., 2010).
Additional correlative evidence comes from the observation
that the distribution of beta oscillations within the STN is con-
centrated in its dorsolateral motor territories (Kuhn et al., 2005;
Alonso-Frech et al., 2006; Weinberger et al., 2006, 2009) and a
recent study has shown that the therapeutic outcome of DBS in
PD is predicted by the extent of the oscillatory activity in this
region (Zaidel et al., 2010). It has also been shown that DBS is
more efficient in reducing bradykinesia and rigidity when applied
exactly where beta oscillations are maximal (Yoshida et al., 2010).
However, the above correlative evidence does not prove that
beta oscillations are mechanistically important to movement
impairment. Proof-of-principle that excessive beta synchrony is
causal would require the demonstration of motor impairment
induced by STN stimulation at beta band frequencies. STN DBS
at 10Hz increases bradykinesia as assessed by section III of the
United Parkinson’s Disease Rating Scale (UPDRS) (Timmermann
et al., 2004). Other studies, which utilise simple finger tapping
tasks, show relative deteriorations in movement performance
during stimulation in the 5–10 and 20–25Hz frequency bands
(Fogelson et al., 2005), particularly when those patients with base-
line performances within the normal range are considered (Chen
et al., 2007; Eusebio et al., 2008). Baseline performance level is
correlated with the extent of motor impairment possibly because
subjects with better performance are less likely to be already
swamped by excessive synchrony at low frequencies. It should also
be noted that deleterious effects of stimulation at low frequency
are relatively frequency selective, as 50Hz stimulation does not
impair movement (Chen et al., 2007).
Adverse effects of low frequency stimulation have been modest
in the above investigations, but a recent study assessing the rate
of force generation in maximal hand grips reported impairments
of about 15%, rising to 22% when only those patients with better
performance at baseline were considered (Chen et al., 2011). Even
this falls short of the 50% or so improvement following levodopa
administration or high-frequency stimulation in the same group
of patients. One possible reason for the differences in the extent
of motor performance changes during high-frequency and low
frequency stimulation could be insufficient temporal pattern-
ing of low frequency stimulation; application of high-frequency
bursts of pulses at ∼20Hz might be necessary to effectively
amplify neural synchrony and lead to more severe motor impair-
ments (Brown, 2007). Nonetheless, these data do leave open the
possibility that, even if DBS suppresses low frequency oscillations,
its full effect may not be solely mediated through this.
STN DBS IN PARKINSON’S DISEASE
The modern history of DBS of BG nuclei essentially starts with
observations made by Benabid and Pollak in Grenoble, although
earlier observations had been made (Hariz et al., 2010). The clini-
cal effect of stimulation was initially incidentally observed during
a thalamotomy procedure where stimulation was applied for
localisation purposes. During surgery, the operator noticed that
stimulation when applied at frequencies greater than 100Hz pro-
duced a reversible effect on the tremor (Benabid et al., 1987). The
efficacy of chronic stimulation applied at the ventral intermediate
nucleus of the thalamus in producing a sustained tremor reduc-
tion was later confirmed in a larger group of patients (Benabid
et al., 1991). In the early 1990’s, experimental data in the parkin-
sonian non-human primate led to the suggestion that lesioning or
stimulating the STN at high-frequency could relieve parkinsonian
symptoms (Bergman et al., 1990; Benazzouz et al., 1993). It did
not take long before this effect was confirmed in patients (Benabid
et al., 1994; Limousin et al., 1995). Since then, several thousands
of patients have been operated upon and numerous studies have
confirmed the efficacy and the safety of the DBS in PD with
some target-dependant specificities (The deep-brain stimulation
for Parkinson’s disease study group, 2001; Rodriguez-Oroz et al.,
2005; Deuschl et al., 2006).
In particular, the long-term efficacy of STN DBS in reduc-
ing both motor and some non-motor symptoms of PD has been
extensively documented worldwide in large patient series (The
deep-brain stimulation for Parkinson’s disease study group, 2001;
Krack et al., 2003; Rodriguez-Oroz et al., 2005; Deuschl et al.,
2006; Witjas et al., 2007; Fasano et al., 2010; Follett et al., 2010)
as well as in a meta-analysis of over 900 patients (Kleiner-Fisman
et al., 2006). The average long-term improvement inmotor symp-
toms assessed using the UPDRS III scale is about 50%—with
a higher efficacy on tremor and rigidity than on bradykine-
sia (Krack et al., 2003). The reduction in levodopa dose is also
about 50% (Benabid et al., 2009). Levodopa-induced dyskinesias
are reduced by 60% after surgery (Krack et al., 2003) although
the mechanisms by which this occurs—levodopa reduction or a
direct effect of DBS—remains debated. Quality of life improves
shortly after STN DBS (Deuschl et al., 2006) but, in contrast
to sustained motor improvements, this effect seems to disap-
pear with time (Volkmann et al., 2009). Both STNs are generally
implanted with electrodes since PD symptoms at this stage of
the disease are bilateral. However, there is some evidence to sug-
gest that unilateral STN DBS may have bilateral effects (Tabbal
et al., 2008; Walker et al., 2009) even though these may not last
(Kim et al., 2009).
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EVIDENCE FOR SUPPRESSION OF BETA BY
HIGH-FREQUENCY STN DBS
Although DBS is remarkably effective in treating movement dis-
orders such as PD, dystonia and essential tremor, the mechanism
underlying this efficacy remain essentially unexplained. In PD,
DBS mimics the effects of lesioning and was therefore initially
considered to inhibit STN or GPi output in keeping with the
classic pathophysiological model of the disease (Albin et al.,
1989; DeLong, 1990). Consistent with this, in vitro recordings in
slice preparations from parkinsonian rats showed a frequency-
dependent decrease in neuronal activity during and after STN
stimulation (Beurrier et al., 2001). This effect was also seen
in vivo in the parkinsonian primate (Meissner et al., 2005). Locally
decreased neuronal activity was also seen during STN and GPi
stimulation of PD patients (Dostrovsky et al., 2000; Welter et al.,
2004). In addition, at the cellular and synaptic level, there is
evidence to suggest that high-frequency stimulation of the STN
reverses some of the abnormalities observed in PD and in particu-
lar glutamatergic hyperactivity consistent with a blockade of STN
activity (Salin et al., 2002; Gubellini et al., 2006). The suppressive
role of STN DBS on neuronal activity is, however, challenged by
the observation that, activity in the SNr, which is a major target
nucleus of the STN, is increased during high-frequency STN stim-
ulation (Maurice et al., 2003). Additionally, recordings obtained
from parkinsonian primates showed a marked increase in GPi
activity during STN stimulation at 130Hz (Hashimoto et al.,
2003). It was more recently shown that STN DBS does not in fact
silence STN neurons in PD patients but rather changes their fir-
ing pattern (Carlson et al., 2010). These apparently contrasting
effects can be reconciled by the observation that DBS is capable
of inhibiting the spontaneous firing of STN and simultaneously
generate a new pattern of activity (Garcia et al., 2003). This is
consistent with the observation that DBS does not have the same
impact on the neuronal soma and axon, suggesting that STN DBS
could uncouple somatic and axonal activity (Holsheimer et al.,
2000; McIntyre et al., 2004).
Nevertheless, these observations regarding the effects of
high-frequency DBS on neuronal activity (Garcia et al., 2005;
Hammond et al., 2008) have failed to provide a satisfactory expla-
nation for the paradoxical effects of DBS on motor function
highlighted over a decade ago (Marsden and Obeso, 1994). One
hypothesis is that PD leads to a pattern of BG activity that dis-
rupts local and distant function and that DBS acts to suppress
this “noisy signal” (Brown and Eusebio, 2008). In PD, the noisy
signal could be excessive beta synchronisation and one tenta-
tive hypothesis would therefore be that STN DBS suppresses beta
oscillations in the STN as well as in its projection targets. Several
computational studies corroborate this hypothesis and suggest
that the efficacy of STN DBS could depend on regularization
of activity patterns and suppression of synchronized oscillatory
activity patterns observed in down-stream nuclei (Rubin and
Terman, 2004; Guo et al., 2008; Cagnan et al., 2009; Dorval et al.,
2010; Hahn and McIntyre, 2010) and that the stimulation ampli-
tude and frequency dependency of DBS efficacy could stem from
whether stimulation is able to effectively suppress and/or regu-
larize the pathological oscillations observed in the BG (Cagnan
et al., 2009; Hahn and McIntyre, 2010). In a recent study, Dorval
et al. highlighted that replacing the state of the art regular 130Hz
stimulation with an irregular stimulation pattern (with a mean
frequency of 130Hz and SD of 78Hz), is not able to reduce
bradykinesia in patients with PD and concurrently suggested,
using a computational model that this could stem from the inef-
fectiveness of irregular high-frequency stimulation in regularizing
BG activity (Dorval et al., 2010).
The evidence that DBS may modulate beta activity in patients
with PD is mixed andmostly indirect. The latter is because simul-
taneous recordings of STN LFPs during DBS were, until recently,
obviated by stimulation-induced electrical artifacts which are sev-
eral orders of magnitude larger than the spontaneous fluctuations
of the LFP (Rossi et al., 2007). So investigators have recorded
at projection sites of the STN, where stimulation artifact is less
of a problem. STN DBS-induced improvement in bradykine-
sia and rigidity (but not tremor) correlates with the degree of
suppression of synchronisation in the beta band at the cortex
(Silberstein et al., 2005) and STN DBS suppresses beta LFP activ-
ity in the pallidum (Brown et al., 2004). Another way round the
problem of stimulation artifact has been to record the imme-
diate after effects of STN DBS in those patients with a delayed
return of bradykinesia and rigidity upon cessation of DBS. Here
results have been mixed. Several studies reported a suppression of
beta activity while therapeutic effects last (Wingeier et al., 2006;
Kuhn et al., 2008; Bronte-Stewart et al., 2009), with the suppres-
sion of beta activity following cessation of DBS correlating with
the degree of residual motor improvement (Kuhn et al., 2008).
However, suppression of beta activity was not replicated in a fur-
ther study (Foffani et al., 2006). The authors of the latter study
have since developed a specially designed amplifier which enables
LFP recordings simultaneously with stimulation of the same site
(Rossi et al., 2007). They have gone on to record from the STN
directly during DBS and again failed to show significant suppres-
sion of LFP power in the beta band (Rossi et al., 2008). Although
this study was a technological feat, not all recordings had peaks in
the beta band prior to DBS so that power suppression may have
been difficult to detect in these cases, a problem compounded by
the recording of some patients on medication. Indeed the same
groups have since published a study showing that high-frequency
STN DBS does suppress simultaneously recorded beta oscilla-
tions, albeit to a lesser extent than with treatment with levodopa
(Giannicola et al., 2010).
A further, more recent, investigation used a similar approach,
but restricted study to the effects of STN DBS in a large sample
of PD patients with evidence of pathological synchrony in the
subthalamic region at baseline, prior to stimulation. DBS pro-
gressively suppressed peaks in LFP activity at frequencies between
11 and 30Hz as stimulation voltage was increased beyond a
threshold of 1.5 V. The latter corresponded to the median thresh-
old for clinical efficacy of high-frequency STN DBS in these
patients (Figure 1). The study provides strong evidence that DBS
can suppress pathological activity at 11–30Hz in the vicinity
of stimulation in patients with PD and that this suppression
occurs at stimulation voltages that are clinically effective (Eusebio
et al., 2011). The suppression of pathological beta oscillations
may therefore provide a common mechanism of action for both
levodopa and STN DBS.
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FIGURE 1 | Effect of DBS of the STN on the LFP. (A) Power autospectrum of
LFP recorded without stimulation. There is a large peak arrowed at 14Hz.
(B) Frequency-time log power spectrum of LFP (contact pair 02). Red bars
along the time axis denote periods of DBS at 2.0–3.0 V, which induced motor
improvement but also dyskinesias of the contralateral foot. Note the
suppression of the 14Hz peak with stimulation = 2.0 V, and the delayed return
of the 14Hz activity after stimulation is terminated. (C) Timing and voltage of
DBS applied at contact 1. (Adapted with permission from Eusebio et al., 2011).
LIMITATIONS OF THE THEORY THAT HIGH-FREQUENCY
STN DBS SUPPRESSES LOCAL BETA ACTIVITY
It cannot, however, be assumed that STN DBS-induced beta sup-
pression is limited to the STN region, or that this is the sole
consequence of stimulation. It is possible that DBS influences
neuronal activity both locally at the site of stimulation (in and
around STN), and also over other functionally connected ele-
ments of the cortex—BG network (Hashimoto et al., 2003; Brown
et al., 2004; Dorval et al., 2008; Hammond et al., 2008; Kuhn
et al., 2008; Montgomery and Gale, 2008). Such propagation may
be both orthodromic and antidromic. For example, the bilat-
eral efficacy of unilateral STN DBS could potentially be partly
explained by the coupling of beta oscillations across the two
STN (de Solages et al., 2010). The propagated effect of STN DBS
on the BG—thalamocortical network has been extensively stud-
ied in several computational studies (Rubin and Terman, 2004;
Guo et al., 2008; Cagnan et al., 2009; Pirini et al., 2009; Dorval
et al., 2010; Hahn and McIntyre, 2010). These studies have been
founded on the hypothesis that thalamus plays a key role in PD
pathophysiology by relaying aberrant BG oscillations to cortex,
forming a closed circuit via the hyper-direct pathway from the
cortex to the STN resonating at beta band frequencies. It has been
suggested that high-frequency stimulation of the STN is effective
since it restores thalamic relay fidelity (Rubin and Terman, 2004;
Guo et al., 2008; Dorval et al., 2010) and disrupts relay of patho-
logical oscillations to cortex via thalamus (Cagnan et al., 2009).
It has also been highlighted that activity patterns rather than rate
are vital in determining modulatory effects of BG output on tha-
lamus and the overall efficacy of DBS (Rubin and Terman, 2004;
Guo et al., 2008; Cagnan et al., 2009; Pirini et al., 2009; Dorval
et al., 2010).
The mechanisms by which STN DBS might induce beta
suppression are also unclear. There is evidence to suggest that
dopamine attenuates beta oscillations through the damping of
resonance phenomena in local circuits (Eusebio et al., 2009).
This may occur through the alteration of voltage-dependent con-
ductances (Nicola et al., 2000) that act to dampen oscillations
(Gutfreund et al., 1995). It seems plausible therefore that STN
DBS might similarly promote damping of circuit resonance in
the beta band. There is evidence both from in vitro recordings
and computational studies to suggest that high-frequency DBS
may modulate local currents and, in particular, potassium and
sodium conductances (Beurrier et al., 2001; Shin and Carlen,
2008; Cagnan et al., 2009).
Although STN DBS seems to suppress pathological beta activ-
ity, this need not imply that STN DBS-induced motor improve-
ment is exclusively due to beta suppression. Certainly a minority
of patients do not have spectral peaks in the beta band during
the post-operative period (Eusebio et al., 2011). Moreover, there
is increasing evidence that beta activity is not directly linked to
parkinsonian tremor (Silberstein et al., 2003; Amirnovin et al.,
2004; Kuhn et al., 2006, 2008, 2009; Weinberger et al., 2006; Ray
et al., 2008), although one early study found a association between
rest tremor and 15–30Hz oscillations (Levy et al., 2000). This
presents a problem, as STN DBS is very effective in suppress-
ing Parkinsonian tremor. Perhaps, elevation of beta is a necessary
pre-requisite for tremor, but not, by itself, sufficient to cause it.
Alternatively, tremor may relate to oscillatory activities in the BG
at other frequencies that are also simultaneously suppressed by
DBS. Two candidate frequencies have been suggested, and need
not be mutually exclusive. First, there are those oscillations at
the frequency of rest tremor, 4–6Hz (Weinberger et al., 2009),
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and its harmonic, 8–12Hz (Rivlin-Etzion et al., 2006). Second,
tremor periods are associated with an elevation in low gamma
(35–55Hz) power in the LFP (Weinberger et al., 2009). Figure 1
suggests that the suppression of LFP activities by STN DBS at
therapeutic voltages may be relatively indiscriminate and extend
to both sub-beta band and low gamma activities, although the
amplifier design precludes assessment of frequencies over 40Hz.
The potential local suppression of low gamma activity by STN
DBS should be distinguished from its potential effects at even
higher frequencies. Thus, it has been suggested that some of the
effects of DBSmay relate to the driving of neurons and axons near
the point of stimulation (Garcia et al., 2005; Hammond et al.,
2008; Montgomery and Gale, 2008). STN DBS may drive sub-
thalamic activity at stimulation frequency (Meissner et al., 2006),
with this activity then being propagated to other sites (Hashimoto
et al., 2003; Brown et al., 2004). This effect might mimic the
increase in synchrony at high gamma (>55Hz) frequencies that
follows treatment with levodopa (Brown et al., 2001; Foffani et al.,
2003), although the evidence that high-frequency oscillations are
functionally relevant in restoring normal motor function in PD
patients is not so far compelling.
IMPLICATIONS FOR THE FUTURE OF DBS THERAPY
Although current fixed stimulation DBS regimes afford good
control of motor symptoms in PD, they are by no means perfect.
In particular, some side-effects may relate to the indiscriminate
suppression or over-riding of residual physiological functioning
in BG-cortical circuits (Chen et al., 2006; Ray et al., 2009). A recent
study demonstrated that DBS-induced side-effects can be mini-
mized by using field steering and constraining stimulated regions
(Frankemolle et al., 2010). An alternate approach to improve
DBS is to introduce closed-loop therapy, which involves contin-
ual monitoring of clinical state or surrogate neuronal activity, so
that stimulation need only be delivered when necessary. Here the
idea is that periods of non-stimulation might allow physiological
functioning with limitation of side-effects, less accommodation
to the effects of stimulation and savings in battery power. Indeed,
there is evidence that both the neuronal activity in the BG and
the motor symptoms are highly variable with time (Brown, 2003;
Hammond et al., 2007; Raz et al., 2000), potentially allowing for
intermittent therapy, especially as most patients also still receive
dopaminergic medication. Furthermore, adjusting the stimula-
tion parameters frequently has been shown to better improve
symptom control (Moro et al., 2006). Recently, the group of
Bergman constructed a closed-loop stimulator and compared its
efficacy in reducing motor impairment in parkinsonian primates
to that of continuous high-frequency stimulation. The device
used the activity of cortical neurons to determine when to deliver
short trains of high-frequency simulation to the GPi. They found
that the closed-loop strategy was superior to standard DBS in
both alleviating the symptoms and suppressing the pathologi-
cal oscillatory activity (Rosin et al., 2011). As well as providing
further support for the pathological role of oscillations in PD
these important results pave the way for future studies in patients.
Nevertheless, the approach taken in this proof-of-principle study
may not be the most suitable for clinical translation. This is
because of difficulties in maintaining recordings of the activities
of single neurons over time and the necessity for two surgical
targets (cortical and pallidal). The strong correlation between beta
activity and bradykinesia-rigidity suggests that this might provide
an alternative biomarker, evident in the LFP and therefore more
robust over time, and able to be detected from the very site of
stimulation (Stanslaski et al., 2009). Importantly, and as discussed
here, this beta activity is likely tobe suppressedby successfulDBS, a
critical feature of any signal to be used for feedback control ofDBS.
The advantage of the above approach is that it relies only on a
strong correlation between beta activity andmotor impairment at
any given time. However, the growing evidence that exaggerated
beta synchrony may be mechanistically linked to motor impair-
ment in PD suggests another and more sophisticated approach.
Here, the temporal patterning of stimulation is organised so
that it specifically targets the putative pathological activity. There
are several approaches that can be taken (Tukhlina et al., 2007;
Hauptmann and Tass, 2010; Guo and Rubin, 2011), but per-
haps the most intuitive is phase cancellation as practised in noise
reducing headphones. The advantage is that this would target
pathological activity but leave physiological processing relatively
untouched, thereby limiting side-effects.
In conclusion, we have reviewed evidence that high-frequency
STN DBS suppresses excessive beta synchrony in PD and that this
is—at least in part—responsible for the improvement in motor
symptoms. Several issues remain unresolved and in particular
the mechanisms by which STN DBS suppresses beta oscillations
and the possibility that other consequences of high-frequency
STN DBS—unrelated to beta suppression—may contribute to
symptomatic improvement.
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